CRISPR-CasΦ from huge phages is a hypercompact genome editor.
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
17 07 2020
17 07 2020
Historique:
received:
05
02
2020
accepted:
06
05
2020
entrez:
18
7
2020
pubmed:
18
7
2020
medline:
11
8
2020
Statut:
ppublish
Résumé
CRISPR-Cas systems are found widely in prokaryotes, where they provide adaptive immunity against virus infection and plasmid transformation. We describe a minimal functional CRISPR-Cas system, comprising a single ~70-kilodalton protein, CasΦ, and a CRISPR array, encoded exclusively in the genomes of huge bacteriophages. CasΦ uses a single active site for both CRISPR RNA (crRNA) processing and crRNA-guided DNA cutting to target foreign nucleic acids. This hypercompact system is active in vitro and in human and plant cells with expanded target recognition capabilities relative to other CRISPR-Cas proteins. Useful for genome editing and DNA detection but with a molecular weight half that of Cas9 and Cas12a genome-editing enzymes, CasΦ offers advantages for cellular delivery that expand the genome editing toolbox.
Identifiants
pubmed: 32675376
pii: 369/6501/333
doi: 10.1126/science.abb1400
pmc: PMC8207990
mid: NIHMS1702779
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
333-337Subventions
Organisme : NHGRI NIH HHS
ID : RM1 HG009490
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI142817
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Références
Mol Cell. 2017 Apr 20;66(2):221-233.e4
pubmed: 28431230
Science. 2019 Jan 4;363(6422):88-91
pubmed: 30523077
Science. 2018 Nov 16;362(6416):839-842
pubmed: 30337455
PLoS Genet. 2012;8(5):e1002651
pubmed: 22589730
Science. 2018 Aug 31;361(6405):866-869
pubmed: 30166482
Annu Rev Microbiol. 2006;60:327-49
pubmed: 16824010
Nat Protoc. 2007;2(7):1565-72
pubmed: 17585298
Science. 2007 Mar 23;315(5819):1709-12
pubmed: 17379808
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Nat Biotechnol. 2016 Mar;34(3):339-44
pubmed: 26789497
Elife. 2020 Jun 10;9:
pubmed: 32519675
RNA Biol. 2019 Apr;16(4):504-517
pubmed: 30109815
Mol Cell. 2019 Feb 7;73(3):589-600.e4
pubmed: 30639240
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
Mol Cell. 2015 Nov 5;60(3):385-97
pubmed: 26593719
EMBO Rep. 2009 Feb;10(2):144-51
pubmed: 19165139
Science. 2018 Apr 27;360(6387):436-439
pubmed: 29449511
Cell. 2015 Oct 22;163(3):759-71
pubmed: 26422227
Nat Rev Microbiol. 2017 Mar;15(3):169-182
pubmed: 28111461
Cell. 2018 Mar 8;172(6):1239-1259
pubmed: 29522745
Nature. 2016 Apr 28;532(7600):517-21
pubmed: 27096362
Nature. 2016 Oct 13;538(7624):270-273
pubmed: 27669025
Nature. 2017 Feb 9;542(7640):237-241
pubmed: 28005056
Nat Rev Microbiol. 2019 Jan;17(1):7-12
pubmed: 30171202
Nature. 2019 Feb;566(7743):218-223
pubmed: 30718774
Nat Struct Mol Biol. 2019 Apr;26(4):315-321
pubmed: 30936531
Nat Rev Microbiol. 2020 Feb;18(2):67-83
pubmed: 31857715
Nature. 2020 Feb;578(7795):425-431
pubmed: 32051592
Science. 2017 Apr 28;356(6336):438-442
pubmed: 28408723